510(k) Report

510(k) · Cleared

Cleared

Acticoat Foam Dressing, Algisite M Calcium Alginate Dressing

K002896510(k) TraditionalCleared Feb 21, 2001156-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

The Westaim Corp. · FRO Dressing, Wound, Drug

Cleared on Feb 21, 2001 as substantially equivalent to K000051 (Westaim Biomedical, Inc., 2000) and 1 other predicate after a 156-day review. Its family tree reaches back 2 generations to 1991. 83 later devices descend from it.

Decided
Feb 21, 2001
Review
156 days
Class
Class U
Product code
FRO
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K914575 (1991). 4 ancestors in all. 83 later devices descend from it, 5 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2000: 1 other ancestor1994: 1 other ancestor2006: 4 descendants cleared2003: 2 descendants cleared2007: 2 descendants cleared2004: 5 descendants cleared2014: 4 descendants cleared2009: 7 descendants cleared2008: 4 descendants cleared2005: 1 descendant cleared2013: 4 descendants cleared2023: 6 descendants cleared2020: 3 descendants cleared2010: 6 descendants cleared2011: 1 descendant cleared2015: 7 descendants cleared2016: 2 descendants cleared2019: 4 descendants cleared2018: 4 descendants cleared2012: 3 descendants cleared2022: 2 descendants cleared2017: 3 descendants cleared2024: 5 descendants cleared2026: 1 descendant cleared2021: 3 descendants clearedK914575 · Sorbsan Topical Wound Dressing (Modified) · Dow B. Hickam, Inc. · 1991K983210 · Algisite M · Smith & Nephew, Inc. · 19981990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 1 other ancestor 1 generation forward: 5 descendants2 generations forward: 15 descendants3 generations forward: 19 descendants4 generations forward: 24 descendants5 generations forward: 13 descendants6 generations forward: 5 descendants7 generations forward: 1 descendant8 generations forward: 1 descendant K983210 · Algisite M · Smith & Nephew, Inc. · 1998K914575 · Sorbsan Topical Wound Dressing (Modified) · Dow B. Hickam, Inc. · 19910+5
  1. Root · 2 generations backK914575 Sorbsan Topical Wound Dressing (Modified)Dow B. Hickam, Inc. · 1991
  2. 1 generation backK983210 Algisite MSmith & Nephew, Inc. · 1998
  3. This deviceK002896 Acticoat Foam Dressing, Algisite M Calcium Alginate DressingThe Westaim Corp. · 2001
  4. Descendant · cites it directly · 53 of its ownK024298 Antimicrobial Alginate DressingAdvanced Medical Solutions, Ltd. · 2003
  5. Descendant · 2 generations on · 25 of its ownK032986 Clo-Surplusp.a.D.Scion Cardio-Vascular, Inc. · 2004
  6. Descendant · 2 generations on · 17 of its ownK033869 Contreet Foam Cavity Dressing with Silver, Model 9628 (2X4 in.)Coloplast Corp. · 2004
  7. Descendant · cites it directly · 16 of its ownK041316 Antimicrobial Alginate DressingAdvanced Medical Solutions, Ltd. · 2004
  8. Descendant · cites it directly · 12 of its ownK022483 Actisorb Silver 220 Antimicrobial Binding DressingJohnson & Johnson Medical, Ltd. · 2003

Showing 5 of 83 descendants. See all descendants

Descendants cleared per year

2003: 22004: 52005: 12006: 42007: 22008: 42009: 72010: 62011: 12012: 32013: 42014: 42015: 72016: 22017: 32018: 42019: 42020: 32021: 32022: 22023: 62024: 52026: 1
2003high 7 (2009) · low 0 (2025)2026

Most influential descendants

Showing 5 of 83 · See all
  • K024298Antimicrobial Alginate DressingAdvanced Medical Solutions, Ltd. · 2003 · cites it directly53descendants
  • K032986Clo-Surplusp.a.D.Scion Cardio-Vascular, Inc. · 2004 · 2 generations on25descendants
  • K033869Contreet Foam Cavity Dressing with Silver, Model 9628 (2X4 in.)Coloplast Corp. · 2004 · 2 generations on17descendants
  • K041316Antimicrobial Alginate DressingAdvanced Medical Solutions, Ltd. · 2004 · cites it directly16descendants
  • K022483Actisorb Silver 220 Antimicrobial Binding DressingJohnson & Johnson Medical, Ltd. · 2003 · cites it directly12descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K914575Sorbsan Topical Wound Dressing (Modified)Dow B. Hickam, Inc.1991—
−1K983210Algisite MSmith & Nephew, Inc.1998—
0 (this device)K002896Acticoat Foam Dressing, Algisite M Calcium Alginate DressingThe Westaim Corp.2001—
+1K024298Antimicrobial Alginate DressingAdvanced Medical Solutions, Ltd.2003—
+2K032986Clo-Surplusp.a.D.Scion Cardio-Vascular, Inc.2004—
+2K033869Contreet Foam Cavity Dressing with Silver, Model 9628 (2X4 in.)Coloplast Corp.2004—
+1K041316Antimicrobial Alginate DressingAdvanced Medical Solutions, Ltd.2004—
+1K022483Actisorb Silver 220 Antimicrobial Binding DressingJohnson & Johnson Medical, Ltd.2003—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200320
200450
200510
200640
200720
200840
200970
201060
201110
201230
201340
201440
201570
201620
201730
201840
201940
202030
202130
202220
202360
202450
202610
FIG. 1 — Lineage of K002896, 1991–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FRO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FRO device

  1. #1 K261023 Microdacyn Wound Irrigation Solutionscore 15.5 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K000051Acticoat Foam Dressing
Summary page 1
…al classification for wound/burn dressings has not been implemented. Trade Name: Acticoat® Calcium Alginate Dressing Common Name: Alginate Dressing Predicate Devices: K000051 Acticoat® Foam Dressing K983210 Algisite M Calcium Alginate Dressing Indication for Use: The Acticoat® Calcium Alginate Dressin…
Westaim Biomedical, Inc.20001
*K983210Algisite M
Summary page 1
…dressings has not been implemented. Trade Name: Acticoat® Calcium Alginate Dressing Common Name: Alginate Dressing Predicate Devices: K000051 Acticoat® Foam Dressing K983210 Algisite M Calcium Alginate Dressing Indication for Use: The Acticoat® Calcium Alginate Dressing is an effective barrier to bac…
Smith & Nephew, Inc.1998—

Also cleared against K000051: 2 other devices →

What descends from it? (83)

See all 83

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K024298Antimicrobial Alginate DressingAdvanced Medical Solutions, Ltd.200353
K041316Antimicrobial Alginate DressingAdvanced Medical Solutions, Ltd.200416
K022483Actisorb Silver 220 Antimicrobial Binding DressingJohnson & Johnson Medical, Ltd.200312
K070581Silver Alginate II Wound DressingAdvanced Medical Solutions Limited20073
K053590Silverlon CA (Calcium Alginate)Argentum Medical, LLC20061

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 3 companies; a new generation was cleared every 7.0 years on median.
  • 1 of the 4 ancestors has a recall of any class.
  • Of its descendants, K024298 (Advanced Medical Solutions, Ltd., 2003) has gone furthest, with 53 descendants of its own.
  • 2 other devices also cite its predicate K000051.

How does its category compare?

All FRO devices

FRO Dressing, Wound, Drug: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FRO

11in 2025

2007: 292008: 262009: 312010: 312011: 272012: 242013: 192014: 222015: 282016: 282017: 232018: 202019: 162020: 122021: 82022: 92023: 182024: 242025: 112026 (partial year): 17
2007high 31 (2009) · low 8 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FRO

176in 2025

2007: 187 days median2008: 130 days median2009: 136 days median2010: 146 days median2011: 177 days median2012: 96 days median2013: 194 days median2014: 214 days median2015: 249 days median2016: 222 days median2017: 147 days median2018: 206 days median2019: 270 days median2020: 226 days median2021: 275 days median2022: 332 days median2023: 283 days median2024: 263 days median2025: 176 days median2026 (partial year): 254 days median
2007high 332 (2022) · low 96 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FRO

2in 2024

2007: 42008: 12009: 12011: 42013: 12014: 12015: 22016: 32017: 12019: 12021: 62022: 22023: 2, 2 Class I2024: 22026 (partial year): 2
2007high 6 (2021) · low 0 (2010)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · FRO

192in 2025

2007: 552008: 302009: 452010: 1222011: 422012: 652013: 1392014: 2692015: 2972016: 1472017: 1492018: 1282019: 1362020: 1392021: 1832022: 1762023: 1982024: 2322025: 192
2007high 297 (2015) · low 30 (2008)2025

MAUDE reports naming product code FRO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200729187455
200826130130
200931136145
2010311460122
201127177442
20122496065
2013191941139
2014222141269
2015282492297
2016282223147
2017231471149
2018202060128
2019162701136
2020122260139
202182756183
202293322176
2023182832 (2)198
2024242632232
2025111760192
2026172542—

What is it indicated for?

The Acticoat® Caleium Alginate Dressing is an effective barrier to bacterial penetration., The barrier functions of the dressing may help reduce infection in moderate to heavily exudative partial and full thickness wounds including decubitus ulcers, diabetic ulcers, venous stasis ulcers, surgical and traumatic wounds. Acticoat® dressings may be used over debrided and partial thickness wounds.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K002896: Acticoat Foam Dressing, Algisite M Calcium Alginate Dressing.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K002896

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026